Jeffrey Dao——Operating Officer and Business Development Officer

Mr. Dao has over three decades of experience in the high tech and life science industries. His focus has been the commercialization of novel technology and innovations spanning the fields of artificial intelligence, enterprise applications, data analytics, clinical diagnostics and therapeutics. Mr. Dao’s experience covers a broad spectrum of companies, including one of the first spin-offs of Stanford Research Institute. He has deep operational experience in product management, marketing, commercialization, strategic alliances, corporate development, and mergers and acquisitions. As head of marketing and sales of CIC, Mr. Dao helped the company complete a successful IPO on NASDAQ. He has also been involved in the development of diagnostics and novel therapies for solid tumor cancers. 

Mr. Dao’s previous experience includes Senior Director Business Development, Oracle; VP Business Development, Nokia; Senior VP, Genyous Life Sciences; President & Co-CEO, Omnitura Therapeutics; and Senior VP Marketing and Business Development, Kairoi Health.  


Mr. Dao studied Engineering Physics at the University of California, Berkeley and participated in Stanford University’s Graduate School of Business Executive Education program.


We will contact you as soon as possible

© 2020 HighTide Therapeutics Inc.

Legal StatementPrivacy PolicyCookie Policy


Follow Us

© 2020 HighTide Therapeutics Inc.